Clopidogrel vs Durvalumab

## Clopidogrel vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Clopidogrel** and **Durvalumab**.

## Mechanism of Action

**Clopidogrel**: Irreversibly blocks P2Y12 ADP receptor on platelets.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Clopidogrel — 6 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Clopidogrel — C16H16ClNO2S; Durvalumab — N/A.

**Molecular Weight**: Clopidogrel — 321.8220 g/mol; Durvalumab — N/A.

**Type**: Clopidogrel — Small molecule; Durvalumab — Antibody.